Prostate, Uterus and Adnexa MRI Flashcards
Prostate Anatomy
From an imaging standpoint, what are the two components to the prostate that can be resolved on MR?
Can you distinguish the central zone and transition zone on MR?
In younger men, the central gland is composed mostly of what?
How about in older males?
Describe all the zones of the prostate.
What percent of prostate cancers originate in each zone?
- From an imaging standpoint, there are two components to the prostate that can be resolved on MRI: The peripheral zone and the central gland. The central gland refers to both the central zone and the transition zone, as they cannot be distinguished on MRI.
- In younger men, the central gland is composed mostly of the central zone; however, the transition zone enlarges as benign prostatic hyperplasia develops. These changes result in thecentral gland becoming predominantly composed of the transition zone in older males.
- Transition zone surrounds the prostatic urethra. This zone enlarges in aging men resulting in benign prostatic hyperplasia - makes sense since you get all those BPH symptoms!
- Central zone lies in the base of the prostate behind the transition zone and surrounds the left and the right ejaculatory duct.
- Anterior fibromuscular stroma is a small area of tissue that is situated on the anterior side of the prostate.
- Peripheral zone is situated on the posterior and lateral side of the prostate.
- 70-75% of all prostate cancers originate in the peripheral zone (PZ).
- The posterior aspect of this zone can be examined with digital rectal exam.
- 25% of prostate cancers originate in the transition zone (TZ).
- Very few prostate cancers manifest in the central zone or in the anterior fibromuscular stroma.
What MR sequence can delineate the postatic zonal anatomy?
What is used to enhance the image?
- MRI is able to clearly delineate the prostatic zonal anatomy (central gland versus peripheral zone) with T2-weighted sequences.
- Imaging is enhanced with an endorectal coil.
Can we screen for prostate cancer with MR?
- MRI is inappropriate for screening due to cost and low sensitivity and specificity.
What is the typical MR appearance of prostate cancer?
Does prostate cancer show diffusion restriction?
What does dynamic contrast-enhanced MR typically show?
MR spect may show what in prostate cancer?
- The typical MRI appearance of prostate cancer is a T2 hypointense region within the T2 hyperintense peripheral zone.
- Prostate cancer typically shows restricted diffusion.
- Dynamic contrast-enhanced MRI typically shows prostate cancer to have early enhancement relative to the peripheral zone.
- MRI spectroscopy of prostate cancer may show elevated choline and depressed citrate peaks compared to normal prostate.
Can MR detect all prostate cancers? If so, why not?
- MRI may not detect all prostate cancer because:
- Some cancer is not hypointense on T2- weighted images
- Central zone cancers are difficult to detect on T2-weighted images
- Cancer conspicuity is decreased if the peripheral zone is not T2 hyperintense.
Is MR specific in diagnosing prostate cancer?
What is the DDx of a region of peripheral zone T2 hypointensity?
What techniques can be sued to increase specificity?
- MRI is not specific: In addition to prostate cancer, the differential diagnosis of a region of peripheral zone T2 hypointensity includes
- Prostatitis
- Hemorrhage
- Involutional changes from androgen-deprivation therapy.
- Advanced MRI techniques, such as MRI spectroscopy, dynamic contrast-enhanced imaging, and diffusion imaging may increase specificity.
What is the most important goal of prostate MR?
- The most important goal of MRI is to distinguish between surgical and nonsurgical disease.
- Cancer that is contained within the gland (tumor stage T2) is generally amenable to radical prostatectomy.
- Cancer that has spread outside of the gland (T3 and above) is typically treated non surgically (e.g., anti-androgen and radiation therapy).
- Per Dr. Parker: something like to double check if a bx of a prostate cancer is actually consistent with disease burden (since its more difficult to bx the anterior portion of the prostate)
MR TNM staging of prostate cancer
- T-staging:
- T1: Tumor apparent by biopsy only.
- T2: Tumor confined within the prostate.
- T2a: <50% of one lobe
- T2b: >50% of one lobe
- T2c : Tumor involves both lobes.
- T3: Tumor extends through the prostate capsule. May involve seminal vesicles.
- T3a: Extracapsular extension
- T3b: Invasion of seminal vesicles
- T4: Tumor invades adjacent structures other than seminal vesicles.
- N-staging: Any regional lymph node metastasis is N1; however, extra-pelvic nodes are M1a.
- M-staging:
- M0: No metastases.
- M1a: Nonregional lymph nodes
- M1b : Bone metastasis
- M1c : Other metastasis.
- M0: No metastases.
Example of T2a Prostate Cancer
- Staging example: T2a prostate cancer, which can be treated with radical prostatectomy.
Example of T3b N1 Prostate Cancer
- Staging example: T3b N1 prostate cancer, which is typically treated non surgically.
PI-RADS V2
What is it? Based on the findings of what MRI parameters?
What does PI-RADS determine?
- The PI-RADS assessment categories are based on the findings of multiparametric MRI, which is a combination of T2-weighted (T2W), diffusion weighted imaging (DWI) and dynamic contrast-enhanced (DCE) imaging.
- Although there is debate about the value of using DCE imaging, it is still included in the PIRADS version 2.0.
- The PI-RADS assessment category determines the likelihood of clinically significant prostate cancer, which is defined as a tumor with a Gleason score of 7 or more.
Gleason Score
- The Gleason score is used by pathologists to grade prostate cancers. If the cancer cells and their growth patterns look very abnormal, a grade of 5 is assigned.
- Since prostate cancers often have areas with different grades, a grade is assigned to the two areas that make up most of the cancer.
- These 2 grades are added to yield the Gleason score.
- The highest Gleason score therefore is 10.
- The first number assigned is the grade that is most common in the tumor.
- For example, if the Gleason score is written as 3+4=7, it means that most of the tumor is grade 3 and the second most common grade is 4.
- A new pathology grading system was recently proposed by the International Society of Urological Pathology (ISUP), dividing the relavant Gleason scores into 5 Grade Groups to simplify prostate cancer grading (table).
PI-RADS Assesment Categories
Based on what sequences?
Where is the peripheral zone of the prostate located?
What is the primary determining MR sequence to assign PI-RADS assessment in the peripheral zone?
Where is the transition zone of the prostate?
What is the primary determining MR sequence to assign PI-RADS assessment in the transition zone?
- Assignment of a PI-RADS assessment category for each lesion is based on the scoring of T2w, DWI/ADC, and DCE sequences, according to zonal anatomy.
- Peripheral zone (PZ): The peripheral zone is situated on the posterior and lateral side of the prostate, surrounding the transition zone. For the peripheral zone the DWI/ADC is the primary determining sequence (dominant technique) to assign the PI-RADS assessment category (figure). Since the dominant sequence for PI-RADS assessment in the peripheral zone is different from the transition zone, identification of the zonal location of a lesion is vital.
- Transition zone (TZ): The transition zone surrounds the prostatic urethra and enlarges in aging men as a result of benign prostatic hyperplasia. For the transition zone the T2w imaging is the primary determining sequence (dominant technique) to assign the PI-RADS assessment category.
PI-RADS in Peripheral Zone
Assessment category of a lesion is determined primarily on what sequence and correlated to what images?
- In the peripheral zone, the PI-RADS assessment category of a lesion is determined primarily on DWI/ADC and correlated to T2W-images.
- Examples of PI-RADS 1-5 are given in the table.
What is the role of DCE for PI-RADS in the peripheral zone?
- In the peripheral zone an equivocal lesion (PI-RADS category 3) is assigned to PI-RADS category 4 if DCE is positive, i.e focal or earlier contrast enhancement.
- The lesion remains assigned to PI-RADS category 3 if the DCE is negative, i.e. no early enhancement or diffuse enhancement and not corresponding to the focal T2W / DWI lesion or focal enhancement corresponding to BPH.